MY122042A - Pro-drugs and counterparts of camptothecin, their application as medicines - Google Patents

Pro-drugs and counterparts of camptothecin, their application as medicines

Info

Publication number
MY122042A
MY122042A MYPI97006216A MYPI9706216A MY122042A MY 122042 A MY122042 A MY 122042A MY PI97006216 A MYPI97006216 A MY PI97006216A MY PI9706216 A MYPI9706216 A MY PI9706216A MY 122042 A MY122042 A MY 122042A
Authority
MY
Malaysia
Prior art keywords
oxepino
indolizino
ethy
dione
dihydro
Prior art date
Application number
MYPI97006216A
Inventor
Bigg Dennis
Harnett Jerry
Lanco Christophe
Lavergne Olivier
Liberatore Anne-Marie
Rolland Alain
Original Assignee
Ipsen Pharma Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9615775A external-priority patent/FR2757515B1/en
Application filed by Ipsen Pharma Sas filed Critical Ipsen Pharma Sas
Publication of MY122042A publication Critical patent/MY122042A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

THE INVENTION CONCERNS NEW CAMPTOTHECIN ANALOGUES, AND PARTICULARLY THE COMPOUNDS OF FOLLOWING FORMULA: -8-ETHY 1-8.9-DIHYDRO-8-HYDROXY-1-BENZYL-2H.10H.12H-[1.3]OXAZINO[5.6-F]OXEPINO[3'.4':6.7]INDOLIZINO[1.2-B]QUINOLINE-10.13(15H)-DIONE; -5-ETHY 1-9,10-DIFLUORO-4,5-DIHYDRO-5-(2-AMINO-1-OXOETHOXY)-1H-OXEPINO[3',4':6,7]INDOLIZINO[1,2-B]QUINNOLINE-3,15(4H,13H)-DIONE; 5-ETHY 1-9,10-DIFLUORO-4,5-DIHYDRO-5(2-AMINO-1-OXOPROPOXY)-1H-OXEPINO[3',4';6,7]INDOLIZINO[1,2-B]QUINOLINE-3,15(4H,13H)-DIONE; THEIR PREPARATION PROCESS,THEIR MEDICAL APPLICATION,THE PHARMACEUTICAL COMPOSITION CONTAINING THEM AND THEIR USE TO PREPARE ANTI-TUMORAL,ANTI-VIRAL AND ANTI PARASITIC DRUGS.
MYPI97006216A 1996-12-20 1997-12-20 Pro-drugs and counterparts of camptothecin, their application as medicines MY122042A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615775A FR2757515B1 (en) 1996-12-20 1996-12-20 PRODROUGAL FORMS AND NEW CAMPTOTHECIN ANALOGS, PROCESSES FOR THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR9615945 1996-12-24

Publications (1)

Publication Number Publication Date
MY122042A true MY122042A (en) 2006-03-31

Family

ID=26233188

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI97006216A MY122042A (en) 1996-12-20 1997-12-20 Pro-drugs and counterparts of camptothecin, their application as medicines

Country Status (24)

Country Link
EP (1) EP0946566B1 (en)
JP (1) JP3576174B2 (en)
KR (1) KR100516873B1 (en)
CN (1) CN1090634C (en)
AR (1) AR005849A1 (en)
AT (1) ATE253582T1 (en)
AU (1) AU734512B2 (en)
BR (1) BR9713977B1 (en)
CA (1) CA2275345C (en)
CZ (1) CZ299794B6 (en)
DE (1) DE69726007T2 (en)
DK (1) DK0946566T3 (en)
ES (1) ES2206760T3 (en)
HK (1) HK1024694A1 (en)
HU (1) HUP0001385A3 (en)
IL (2) IL129892A0 (en)
MY (1) MY122042A (en)
NO (1) NO324973B1 (en)
NZ (1) NZ335938A (en)
PL (1) PL188109B1 (en)
PT (1) PT946566E (en)
TW (1) TW410224B (en)
UA (1) UA57757C2 (en)
WO (1) WO1998028304A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790261B1 (en) * 1999-02-26 2004-09-10 Sod Conseils Rech Applic NOVEL OPTICALLY PURE CAMPTOTHECIN ANALOGS AND PROCESSES FOR THEIR PREPARATION
EP1109789B1 (en) * 1998-09-02 2003-07-16 Pharmagenesis, Inc. Triptolide prodrugs having high aqueous solubility
US6207832B1 (en) 1999-04-09 2001-03-27 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
FR2801309B1 (en) * 1999-11-18 2002-01-04 Adir NOVEL CAMPTOTHECIN-LIKE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US6350756B1 (en) 2001-01-18 2002-02-26 California Pacific Medical Center Camptothecin derivatives
US6855720B2 (en) 2001-03-01 2005-02-15 California Pacific Medical Center Nitrogen-based camptothecin derivatives
US6403604B1 (en) 2001-03-01 2002-06-11 California Pacific Medical Center Nitrogen-based camptothecin derivatives
US20040077674A1 (en) * 2002-03-01 2004-04-22 Curran Dennis P. Mappicine analogs, intermediates in the synthesis of mappicine analogs and methods of synthesis of mappicine analogs
WO2003101998A1 (en) * 2002-06-03 2003-12-11 California Pacific Medical Center Nitrogen-based homo-camptothecin derivatives
MXPA06006711A (en) * 2003-12-17 2006-08-31 Bionumerik Pharmaceuticals Inc Process for making camptothecin derivatives.
MXPA06011679A (en) * 2004-04-09 2007-01-23 Chugai Pharmaceutical Co Ltd Novel water-soluble prodrug.
ITRM20040288A1 (en) * 2004-06-11 2004-09-11 Sigma Tau Ind Farmaceuti USE OF 7-T-BUTOXYIMINOMETHYL CAMPTOTECIN FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF UTERUS NEOPLASIES.
TW200744603A (en) 2005-08-22 2007-12-16 Chugai Pharmaceutical Co Ltd Novel anticancer concomitant drug
FR2892418B1 (en) * 2005-10-24 2010-10-22 Servier Lab NOVEL CAMPTOTHECIN-LIKE HYDROCARBON E-CYCLATE AMINOESTERIFIED COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
FR2892417B1 (en) * 2005-10-24 2010-10-22 Servier Lab NOVEL AMINOESTERIFIED 7-CYPROCARBON HYDROCARBON COMPOUNDS COMPRISING CAMPTOTHECIN, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
CN100465175C (en) * 2005-11-29 2009-03-04 中国人民解放军第二军医大学 7-bit substituted comptothecine kind compound and pharmaceutical use thereof
CN100441580C (en) * 2006-07-14 2008-12-10 中山大学 Quinolyl dione derivative and its application in preparing antibiotic medicine
CN102746314B (en) * 2011-04-18 2016-07-06 华东师范大学 Containing stablizing the camptothecine compounds of 7 yuan of lactonic rings, preparation method and purposes
WO2023232145A1 (en) * 2022-06-02 2023-12-07 华东师范大学 Small molecule of homocamptothecins and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5391745A (en) * 1992-07-23 1995-02-21 Sloan-Kettering Institute For Cancer Research Methods of preparation of camptothecin analogs
RU2164515C2 (en) * 1995-06-21 2001-03-27 Сосьете де Консей де Решерш э Д'Аппликасьон Сьентифик (СКРАС) Campotecin compounds, methods of preparation thereof, intermediates, and therapeutic compositions

Also Published As

Publication number Publication date
AR005849A1 (en) 1999-07-21
PL188109B1 (en) 2004-12-31
IL129892A (en) 2007-09-20
DK0946566T3 (en) 2004-03-15
ES2206760T3 (en) 2004-05-16
JP3576174B2 (en) 2004-10-13
CN1241192A (en) 2000-01-12
CZ209299A3 (en) 1999-09-15
HUP0001385A2 (en) 2000-10-28
CN1090634C (en) 2002-09-11
KR100516873B1 (en) 2005-09-26
CZ299794B6 (en) 2008-11-26
DE69726007T2 (en) 2004-06-03
BR9713977A (en) 2000-04-11
ATE253582T1 (en) 2003-11-15
PL334092A1 (en) 2000-01-31
AU734512B2 (en) 2001-06-14
BR9713977B1 (en) 2010-06-29
IL129892A0 (en) 2000-02-29
UA57757C2 (en) 2003-07-15
NO324973B1 (en) 2008-01-14
WO1998028304A1 (en) 1998-07-02
NO992997L (en) 1999-08-18
AU5326498A (en) 1998-07-17
NO992997D0 (en) 1999-06-18
EP0946566A1 (en) 1999-10-06
PT946566E (en) 2004-03-31
CA2275345C (en) 2010-01-26
HK1024694A1 (en) 2000-10-20
TW410224B (en) 2000-11-01
CA2275345A1 (en) 1998-07-02
JP2001506270A (en) 2001-05-15
HUP0001385A3 (en) 2002-12-28
DE69726007D1 (en) 2003-12-11
EP0946566B1 (en) 2003-11-05
KR20000062260A (en) 2000-10-25
NZ335938A (en) 2000-04-28

Similar Documents

Publication Publication Date Title
MY122042A (en) Pro-drugs and counterparts of camptothecin, their application as medicines
IL127800A (en) Highly lipophilic 7-substituted camptothecin derivatives and pharmaceutical compositions containing them
RU98101135A (en) NEW CAMPTOTECINE ANALOGUES, METHODS OF PRODUCING, THEIR APPLICATION AS MEDICINES AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS
UA66825C2 (en) Azapolycyclic compounds condensed with aryl
DE69427708D1 (en) STABILIZED MEDICINAL COMPOSITION CONTAINING 10-HYDROXY-7-ETHYLCAMPTOTHECIN AS A LAKTON COMPOUND
MXPA05009245A (en) Pyrazine compounds as transforming growth factor (tgf) inhibitors.
BG103417A (en) Condensed pyrimidine bicyclic derivatives
PL373414A1 (en) 8-methoxy-(1,2,4)triazolo(1,5-a)pyridine derivatives and their use as adenosine receptor ligands
IL132763A0 (en) Novel compounds
NZ505339A (en) Camptothecin tetracyclic derivatives useful for inhibiting topoisomerase I and/or II pyridine intermediates thereof
HUP0105428A2 (en) Utilization of aryl or heteroaryl-azolylcarbinol derivatives in the preparation of a medicament for the treatment of troubles mediated by an excess of substance p
TNSN07485A1 (en) N- (ARYLALKYL) -1H-PYRROLOPYRIDINE -2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
WO2002036135A3 (en) Compositions for antitumour treatment containing ecteinascidin 743
SI1730144T1 (en) Substituted 1,4,8-triazaspiro 4.5 decan-2-one compounds
GEP20022801B (en) Pyridazino [4,5-B]-Quinoline 5-Oxide Derivatives, Their Preparation and Their Use as Glycine Antagonists
PL339897A1 (en) Pharmacological product, pharmacological preparation as well as application of selective pde5 inhibitors
HUP9900438A2 (en) Use of pyrazolo[4,3-d]pyrimidin-7-one derivatives for the preparation of pharmaceutical compositions treaing impotence due to spinal cord injury
HUP9900186A2 (en) Use of lamellarin alkaloids in therapy and pharmaceutical compositions containing them
LT2001078A (en) Use of imidazo[1,5-a]-pyrido[3,2-e]-pyrazinones as medicaments
MY119473A (en) Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them
FR2422640A1 (en) NEW 8B-ALKYL SUBSTITUTE MORPHINANE-6-ONES, THEIR PRODUCTION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM
CA2078869A1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
TNSN01001A1 (en) NOVEL PYRAZOLO [4,3-e] SUBSTITUTED DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS A MEDICAMENT AND METHODS FOR THEIR PREPARATION
HUP0003429A1 (en) Optically pure camptothecin analogues and pharmaceutical compositions containing them, optically pure synthesis intermediates and method for preparing same
ES8103090A1 (en) Spiro-quinolylhydantoins, process for their preparation and pharmaceutical compositions thereof.